BAM
TVRD

Belpointe Asset Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Belpointe Asset Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-42
Closed -$7.37K – 3503
2023
Q1 		$7.37K Hold
42
– – ﹤0.01% 2865
2022
Q4 		$16.1K Buy
+42
New +$16.1K ﹤0.01% 2334